Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 6 , Pages 456-464, November 2010

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

  • Karin Yurko-Mauro

      Affiliations

    • Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
    • Corresponding Author InformationCorresponding author. Tel.: 443-542-2524; Fax: 410-997-7789.
    • ,
  • Deanna McCarthy

      Affiliations

    • Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
    • ,
  • Dror Rom

      Affiliations

    • Prosoft Software, Inc, Wayne, PA, USA
    • ,
  • Edward B. Nelson

      Affiliations

    • Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
    • ,
  • Alan S. Ryan

      Affiliations

    • Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
    • ,
  • Andrew Blackwell

      Affiliations

    • Cambridge Cognition Ltd, Cambridge United Kingdom
    • ,
  • Norman Salem Jr.

      Affiliations

    • Clinical Research Department, Martek Biosciences Corporation, Columbia, MD, USA
    • ,
  • Mary Stedman

      Affiliations

    • Stedman Clinical Trials, Tampa, FL, USA
    • ,
  • on behalf of the MIDAS Investigators

published online 03 May 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of Interest Disclosure: With the exception of Drs. Dror Rom, Andrew Blackwell, and Mary Stedman, the other authors are employed by Martek Biosciences Corporation. Dr. Rom and Dr. Blackwell were consultants to the study. The participating clinical investigators are listed as a group in the acknowledgement section of the manuscript.

 Contributors: Blackwell, Nelson, Rom, Yurko-Mauro contributed to the study concept and design. Blackwell, McCarthy, Nelson, Rom, Yurko-Mauro and Stedman participated in study conduct and collection of the data. Rom had responsibility for the statistical analysis. Blackwell, Nelson, Rom, Ryan, Salem, Yurko-Mauro contributed to the interpretation of data. Blackwell, Ryan, Yurko-Mauro contributed to the drafting of the manuscript and McCarthy, Nelson, Rom, Ryan, Salem, Stedman and Yurko-Mauro participated in the revision of the manuscript. The corresponding author had full access to all data in the study after study unblinding, and had final responsibility for the writing of the report and the decision to submit for publication. The study was funded by Martek Biosciences Corporation.

PII: S1552-5260(10)00040-3

doi:10.1016/j.jalz.2010.01.013

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 6 , Pages 456-464, November 2010

Article Tools

* Image Usage & Resolution